- Home
- MDXH vs UCL Comparison
MDXH vs UCL Comparison
Compare MDXH & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- UCL
- Stock Information
- Founded
- MDXH 2003
- UCL 2014
- Country
- MDXH Belgium
- UCL Hong Kong
- Employees
- MDXH N/A
- UCL N/A
- Industry
- MDXH
- UCL Telecommunications Equipment
- Sector
- MDXH
- UCL Consumer Discretionary
- Exchange
- MDXH Nasdaq
- UCL Nasdaq
- Market Cap
- MDXH 84.6M
- UCL 70.6M
- IPO Year
- MDXH 2021
- UCL 2020
- Fundamental
- Price
- MDXH $2.18
- UCL $1.92
- Analyst Decision
- MDXH Buy
- UCL
- Analyst Count
- MDXH 1
- UCL 0
- Target Price
- MDXH $6.00
- UCL N/A
- AVG Volume (30 Days)
- MDXH 61.1K
- UCL 51.0K
- Earning Date
- MDXH 08-20-2025
- UCL 08-13-2025
- Dividend Yield
- MDXH N/A
- UCL N/A
- EPS Growth
- MDXH N/A
- UCL N/A
- EPS
- MDXH N/A
- UCL 0.09
- Revenue
- MDXH $94,507,000.00
- UCL $92,256,000.00
- Revenue This Year
- MDXH $23.51
- UCL $6.09
- Revenue Next Year
- MDXH $17.68
- UCL $7.01
- P/E Ratio
- MDXH N/A
- UCL $20.26
- Revenue Growth
- MDXH 25.46
- UCL 7.65
- 52 Week Low
- MDXH $1.35
- UCL $0.80
- 52 Week High
- MDXH $3.50
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- MDXH 52.06
- UCL 58.25
- Support Level
- MDXH $2.09
- UCL $1.79
- Resistance Level
- MDXH $2.22
- UCL $1.96
- Average True Range (ATR)
- MDXH 0.10
- UCL 0.14
- MACD
- MDXH -0.01
- UCL -0.02
- Stochastic Oscillator
- MDXH 59.52
- UCL 33.97
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.